OpenURL Connection Search

Select item for more details and to access through your institution.

Zidovudine ameliorates pathology in the mouse model of Duchenne muscular dystrophy via P2RX7 purinoceptor antagonism.
Published in:
Acta Neuropathologica Communications, 2018, v. 6, n. 1, p. N.PAG, doi. 10.1186/s40478-018-0530-4
By:
- Al-Khalidi, Rasha;
- Panicucci, Chiara;
- Cox, Paul;
- Chira, Natalia;
- Róg, Justyna;
- Young, Christopher N. J.;
- McGeehan, Rhiannon E.;
- Ambati, Kameshwari;
- Ambati, Jayakrishna;
- Zabłocki, Krzysztof;
- Gazzerro, Elisabetta;
- Arkle, Stephen;
- Bruno, Claudio;
- Górecki, Dariusz C.
Publication type:
Article
P2X7 purinoceptor alterations in dystrophic mdx mouse muscles: relationship to pathology and potential target for treatment.
Published in:
Journal of Cellular & Molecular Medicine, 2012, v. 16, n. 5, p. 1026, doi. 10.1111/j.1582-4934.2011.01397.x
By:
- Young, Christopher N. J.;
- Brutkowski, Wojciech;
- Lien, Chun-Fu;
- Arkle, Stephen;
- Lochmüller, Hanns;
- Zabłocki, Krzysztof;
- Górecki, Dariusz C.
Publication type:
Article
Increased susceptibility to ATP via alteration of P2X receptor function in dystrophic mdx mouse muscle cells.
Published in:
FASEB Journal, 2006, v. 20, n. 6, p. 610, doi. 10.1096/fj.05-4022com
By:
- Yeung, Davy;
- Zablocki, Krzysztof;
- Chun-Fu Lien;
- Taiwen Jiang;
- Arkle, Stephen;
- Brutkowski, Wojciech;
- Brown, James;
- Lochmuller, Hanns;
- Simon, Joseph;
- Barnard, Eric A.;
- Górecki, Dariusz C.
Publication type:
Article
P2RX7 purinoceptor: a therapeutic target for ameliorating the symptoms of duchenne muscular dystrophy.
Published in:
2015
By:
- Sinadinos, Anthony;
- Young, Christopher N. J.;
- Al-Khalidi, Rasha;
- Teti, Anna;
- Kalinski, Paweł;
- Mohamad, Shafini;
- Floriot, Léonore;
- Henry, Tiphaine;
- Tozzi, Gianluca;
- Jiang, Taiwen;
- Wurtz, Olivier;
- Lefebvre, Alexis;
- Shugay, Mikhail;
- Tong, Jie;
- Vaudry, David;
- Arkle, Stephen;
- doRego, Jean-Claude;
- Górecki, Dariusz C.
Publication type:
journal article

Found: 4

Zidovudine ameliorates pathology in the mouse model of Duchenne muscular dystrophy via P2RX7 purinoceptor antagonism.

P2X7 purinoceptor alterations in dystrophic mdx mouse muscles: relationship to pathology and potential target for treatment.

Increased susceptibility to ATP via alteration of P2X receptor function in dystrophic mdx mouse muscle cells.

P2RX7 purinoceptor: a therapeutic target for ameliorating the symptoms of duchenne muscular dystrophy.